Pancreatic Cancer Research

ResearcherThe University of QueenslandActive in the last 2 years

Mohammad Ali Moni

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0756-1006; OpenAlex author ID A5034828056. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Global dissemination of FC- ϵ RI and p53 signalling perturbation contribute to Dasatinib resistance in Pancreatic Cancer Cell-lines Last author DOI 10.64898/2026.02.22.707324↗
  2. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU). Co-author DOI 10.3389/fimmu.2022.1060957↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. AKM Azad · 1 shared paper, 2026 · strength 0.50
  2. S. M. Zahid Hosen · 1 shared paper, 2022 · strength 0.13
  3. David Goldstein · 1 shared paper, 2022 · strength 0.13
  4. Zhihong Xu · 1 shared paper, 2022 · strength 0.13
  5. Marie Ranson · 1 shared paper, 2022 · strength 0.13
  6. Minoti Vivek Apte · 1 shared paper, 2022 · strength 0.13
  7. Tony Pang · 1 shared paper, 2022 · strength 0.13
  8. Jeremy S. Wilson · 1 shared paper, 2022 · strength 0.13
  9. Chamini Jayamali Perera · 1 shared paper, 2022 · strength 0.13
  10. Steve Gallinger · 1 shared paper, 2022 · strength 0.13
  11. Faiyaz Notta · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.